Drugs / TAK-672
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT04580407 | Apr 2021 → Nov 2022 | acquired hemophilia A | Takeda | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TAK-672 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04580407 ↗ |
| Modality | Protein / enzyme biologic | “B-Domain Deleted Recombinant Porcine Factor VIII” NCT04580407 ↗ |